Q3 2024 EPS Estimates for Exponent, Inc. (NASDAQ:EXPO) Reduced by Analyst

Exponent, Inc. (NASDAQ:EXPOFree Report) – Equities research analysts at William Blair reduced their Q3 2024 earnings per share (EPS) estimates for shares of Exponent in a report issued on Friday, April 26th. William Blair analyst A. Nicholas now anticipates that the business services provider will post earnings of $0.42 per share for the quarter, down from their previous estimate of $0.44. The consensus estimate for Exponent’s current full-year earnings is $1.76 per share. William Blair also issued estimates for Exponent’s Q4 2024 earnings at $0.40 EPS, Q2 2025 earnings at $0.54 EPS, Q3 2025 earnings at $0.48 EPS, Q4 2025 earnings at $0.47 EPS and FY2025 earnings at $2.04 EPS.

Exponent (NASDAQ:EXPOGet Free Report) last announced its earnings results on Thursday, April 25th. The business services provider reported $0.59 EPS for the quarter, topping the consensus estimate of $0.46 by $0.13. Exponent had a net margin of 18.72% and a return on equity of 28.13%. The firm had revenue of $137.21 million for the quarter, compared to the consensus estimate of $125.98 million. During the same quarter last year, the firm posted $0.56 EPS. The business’s quarterly revenue was up 6.6% on a year-over-year basis.

Other research analysts also recently issued reports about the company. Truist Financial lifted their price target on Exponent from $95.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday. StockNews.com raised shares of Exponent from a “sell” rating to a “hold” rating in a research report on Monday, March 4th.

Check Out Our Latest Report on Exponent

Exponent Stock Performance

Exponent stock opened at $91.91 on Monday. The business’s 50-day simple moving average is $80.23 and its 200-day simple moving average is $81.85. Exponent has a 52 week low of $64.61 and a 52 week high of $102.72. The firm has a market capitalization of $4.66 billion, a PE ratio of 46.42 and a beta of 0.68.

Exponent Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 21st. Investors of record on Friday, June 7th will be given a dividend of $0.28 per share. The ex-dividend date is Friday, June 7th. This represents a $1.12 dividend on an annualized basis and a yield of 1.22%. Exponent’s dividend payout ratio (DPR) is presently 56.57%.

Insider Activity at Exponent

In other Exponent news, insider Eric Guyer sold 1,650 shares of the business’s stock in a transaction dated Tuesday, April 30th. The shares were sold at an average price of $92.58, for a total value of $152,757.00. Following the completion of the transaction, the insider now directly owns 1,846 shares of the company’s stock, valued at $170,902.68. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 2.20% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Operose Advisors LLC acquired a new position in shares of Exponent in the third quarter valued at $39,000. Benjamin F. Edwards & Company Inc. grew its position in shares of Exponent by 866.0% in the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 512 shares of the business services provider’s stock valued at $42,000 after buying an additional 459 shares during the last quarter. Janiczek Wealth Management LLC grew its holdings in Exponent by 293.7% during the 1st quarter. Janiczek Wealth Management LLC now owns 626 shares of the business services provider’s stock worth $52,000 after acquiring an additional 467 shares during the period. Principal Securities Inc. bought a new position in shares of Exponent in the 4th quarter worth about $69,000. Finally, YHB Investment Advisors Inc. acquired a new position in shares of Exponent in the 1st quarter valued at about $75,000. Institutional investors and hedge funds own 92.37% of the company’s stock.

About Exponent

(Get Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

See Also

Earnings History and Estimates for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.